114 related articles for article (PubMed ID: 16368688)
1. Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase.
Mitchell MS; Tözsér J; Princler G; Lloyd PA; Auth A; Derse D
J Biol Chem; 2006 Feb; 281(7):3964-71. PubMed ID: 16368688
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity.
Trentin B; Rebeyrotte N; Mamoun RZ
J Virol; 1998 Aug; 72(8):6504-10. PubMed ID: 9658093
[TBL] [Abstract][Full Text] [Related]
3. Identification of the RT-RH/IN cleavage site of HTLV-I.
Mariani VL; Shuker SB
Biochem Biophys Res Commun; 2003 Jan; 300(2):268-70. PubMed ID: 12504078
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.
Agbuya PG; Sherman NE; Moen LK
Arch Biochem Biophys; 2001 Aug; 392(1):93-102. PubMed ID: 11469799
[TBL] [Abstract][Full Text] [Related]
5. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.
Boso G; Örvell C; Somia NV
J Virol; 2015 Jan; 89(2):1286-97. PubMed ID: 25392207
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
Sluis-Cremer N; Arion D; Abram ME; Parniak MA
Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.
Olivares I; Mulky A; Boross PI; Tözsér J; Kappes JC; López-Galíndez C; Menéndez-Arias L
J Mol Biol; 2007 Sep; 372(2):369-81. PubMed ID: 17651754
[TBL] [Abstract][Full Text] [Related]
8. trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.
Stewart L; Vogt VM
J Virol; 1991 Nov; 65(11):6218-31. PubMed ID: 1717719
[TBL] [Abstract][Full Text] [Related]
9. Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activity.
Goobar-Larsson L; Bäckbro K; Unge T; Bhikhabhai R; Vrang L; Zhang H; Orvell C; Strandberg B; Oberg B
Virology; 1993 Oct; 196(2):731-8. PubMed ID: 7690504
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
García-Lerma JG; Nidtha S; Heneine W
J Infect Dis; 2001 Aug; 184(4):507-10. PubMed ID: 11471110
[TBL] [Abstract][Full Text] [Related]
11. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
Wapling J; Moore KL; Sonza S; Mak J; Tachedjian G
J Virol; 2005 Aug; 79(16):10247-57. PubMed ID: 16051818
[TBL] [Abstract][Full Text] [Related]
12. Crystal Structure of a Retroviral Polyprotein: Prototype Foamy Virus Protease-Reverse Transcriptase (PR-RT).
Harrison JJEK; Tuske S; Das K; Ruiz FX; Bauman JD; Boyer PL; DeStefano JJ; Hughes SH; Arnold E
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452360
[TBL] [Abstract][Full Text] [Related]
13. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
[TBL] [Abstract][Full Text] [Related]
14. Structure/function studies of HIV-1(1) reverse transcriptase: dimerization-defective mutant L289K.
Goel R; Beard WA; Kumar A; Casas-Finet JR; Strub MP; Stahl SJ; Lewis MS; Bebenek K; Becerra SP; Kunkel TA
Biochemistry; 1993 Dec; 32(48):13012-8. PubMed ID: 7694651
[TBL] [Abstract][Full Text] [Related]
15. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
Mulky A; Sarafianos SG; Jia Y; Arnold E; Kappes JC
J Mol Biol; 2005 Jun; 349(4):673-84. PubMed ID: 15893326
[TBL] [Abstract][Full Text] [Related]
16. Intramolecular chimeras of the p51 subunit between HIV-1 and FIV reverse transcriptases suggest a stabilizing function for the p66 subunit in the heterodimeric enzyme.
Tasara T; Amacker M; Hübscher U
Biochemistry; 1999 Feb; 38(5):1633-42. PubMed ID: 9931031
[TBL] [Abstract][Full Text] [Related]
17. Insertion of a peptide from MuLV RT into the connection subdomain of HIV-1 RT results in a functionally active chimeric enzyme in monomeric conformation.
Pandey PK; Kaushik N; Talele TT; Yadav PN; Pandey VN
Mol Cell Biochem; 2001 Sep; 225(1-):135-44. PubMed ID: 11716355
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.
Mitchell MS; Bodine ET; Hill S; Princler G; Lloyd P; Mitsuya H; Matsuoka M; Derse D
J Virol; 2007 May; 81(9):4422-8. PubMed ID: 17287279
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cells.
Davis AJ; Carr JM; Bagley CJ; Powell J; Warrilow D; Harrich D; Burrell CJ; Li P
Retrovirology; 2008 Dec; 5():115. PubMed ID: 19091128
[TBL] [Abstract][Full Text] [Related]
20. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.
Mulky A; Vu BC; Conway JA; Hughes SH; Kappes JC
J Mol Biol; 2007 Feb; 365(5):1368-78. PubMed ID: 17141805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
